 Connection
Jawahar Mehta to Heart Failure
This is a "connection" page, showing publications Jawahar Mehta has written about Heart Failure.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.524 |
|
|
|
-
Kumar A, Ravi R, Sivakumar RK, Chidambaram V, Majella MG, Sinha S, Adamo L, Lau ES, Al'Aref SJ, Asnani A, Sharma G, Mehta JL. Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis. Curr Probl Cardiol. 2023 Feb; 48(2):101461.
Score: 0.576
-
Calcaterra G, Bassareo PP, Barill? F, Sergi D, Chiocchi M, Romeo F, Mehta JL. The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High. Curr Cardiol Rev. 2021; 17(1):74-77.
Score: 0.508
-
Mehta JL. Suicide, Depression, and Cardiovascular Disease. JACC Heart Fail. 2020 06; 8(6):519.
Score: 0.488
-
Goel A, Kattoor AJ, Mehta JL. Thiamin therapy for chronic heart failure: is there any future for this vitamin? Am J Clin Nutr. 2019 12 01; 110(6):1270-1271.
Score: 0.472
-
Kattoor AJ, Goel A, Mehta JL. Thiamine Therapy for Heart Failure: a Promise or Fiction? Cardiovasc Drugs Ther. 2018 08; 32(4):313-317.
Score: 0.430
-
Ayoub KF, Pothineni NVK, Rutland J, Ding Z, Mehta JL. Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets. Cardiovasc Drugs Ther. 2017 Dec; 31(5-6):593-608.
Score: 0.411
-
Shirazi LF, Bissett J, Romeo F, Mehta JL. Role of Inflammation in Heart Failure. Curr Atheroscler Rep. 2017 Jun; 19(6):27.
Score: 0.397
-
Mehta JL, Pothineni NV. Inflammation in Heart Failure: The Holy Grail? Hypertension. 2016 07; 68(1):27-9.
Score: 0.368
-
Joseph J, Rimawi A, Mehta P, Cottler-Fox M, Sinha A, Singh BK, Pacheco R, Smith ES, Mehta JL. Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure. Am J Cardiol. 2006 Mar 01; 97(5):681-4.
Score: 0.180
-
Ghanta SN, Gautam N, Mehta JL, Al'Aref SJ. Machine Learning for Predicting Intubations in Heart Failure Patients: the Challenge of the Right Approach. Cardiovasc Drugs Ther. 2024 Apr; 38(2):211-214.
Score: 0.146
-
Cheng W, Cui C, Liu G, Ye C, Shao F, Bagchi AK, Mehta JL, Wang X. NF-?B, A Potential Therapeutic Target in Cardiovascular Diseases. Cardiovasc Drugs Ther. 2023 06; 37(3):571-584.
Score: 0.141
-
Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022 02 05; 21(1):20.
Score: 0.137
-
Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. Am Heart J. 2021 02; 232:10-22.
Score: 0.125
-
Salah HM, Mehta JL. Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19. J Cardiovasc Pharmacol Ther. 2021 03; 26(2):114-118.
Score: 0.125
-
Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, Shah N, Chothani A, Savani GT, Mehta K, Parikh V, Rathod A, Badheka AO, Lafferty J, Kowalski M, Mehta JL, Mitrani RD, Viles-Gonzalez JF, Paydak H. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014 Jun 10; 129(23):2371-9.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|